NCT06367829View on ClinicalTrials.gov

Lubinus SPII Hip Stem Target Trial Emulation (LARGE)

Enrolling by invitationOBSERVATIONAL
Enrollment

110,000

Participants

Timeline

Start Date

January 8, 2024

Primary Completion Date

May 14, 2025

Study Completion Date

December 31, 2025

Conditions
Treatment Outcome
Interventions
PROCEDURE

Lubinus SPII hip stem 130mm

Shorter length of the SPII hip stem

PROCEDURE

Lubinus SPII hip stem 150mm

Longer length of the SPII hip stem

Trial Locations (1)

1090 HM

OLVG, Amsterdam

Sponsors

Lead Sponsor

JointResearch
All Listed Sponsors
collaborator

OLVG

NETWORK

collaborator

Uppsala University

OTHER

collaborator

Göteborg University

OTHER

collaborator

Leiden University Medical Center

OTHER

lead

JointResearch

OTHER